Picton Mahoney Asset Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Picton Mahoney Asset Management’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-40,000	Closed	-$68K	–	400
2020 Q3	$68K	Sell	40,000 -10,000	-20%	-$16.4K	﹤0.01%	326
2020 Q2	$74K	Buy	+50,000	New	+$71.7K	﹤0.01%	295

Other funds holding STLNW

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.14% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

Picton Mahoney Asset Management's STLNW Position: Q4 2020 in Review

Picton Mahoney Asset Management sold out of Starling Oncology, Inc. Warrant (STLNW) in Q4 2020, closing a stake of 40,000 shares — an estimated $68K sold.

Picton Mahoney Asset Management first reported a position in STLNW in Q2 2020 and held it in 2 quarters. The position peaked at $74K in Q2 2020. 25 funds tracked by Wall St. Rank hold STLNW as of Q4 2020.

Picton Mahoney Asset Management reported no remaining Starling Oncology, Inc. Warrant position as of Q4 2020 after selling out during the quarter.
Picton Mahoney Asset Management sold 40,000 Starling Oncology, Inc. Warrant shares in Q4 2020, an estimated $68K.
Picton Mahoney Asset Management first reported a position in Starling Oncology, Inc. Warrant in Q2 2020 and held it in 2 quarters.
Picton Mahoney Asset Management's Starling Oncology, Inc. Warrant position peaked at $74K in Q2 2020.
25 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q4 2020.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.